Natural antibody response to Plasmodium falciparum merozoite antigens MSP5, MSP9 and EBA175 is associated to clinical protection in the Brazilian Amazon

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Medeiros, Márcia M ^a   Fotoran, Wesley L ^a   dalla Martha, Rosimeire C ^b   Katsuragawa, Tony H ^b   Pereira da Silva, Luiz H ^b   Wunderlich, Gerhard ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Research Center for Tropical Medicine CEPEM/Tropical Pathology Research Institute IPEPATRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMA1 PROTEIN; EBA175 ANTIGEN; EBL PROTEIN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; MEMBRANE ANTIGEN; MSP PROTEIN; MSP5 ANTIGEN; MSP9 ANTIGEN; PARASITE ANTIGEN; PROTOZOAL PROTEIN; RECOMBINANT ANTIGEN; UNCLASSIFIED DRUG;

ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; ASYMPTOMATIC DISEASE; BLOOD ANALYSIS; BRAZIL; CONTROLLED STUDY; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOREACTIVITY; MALE; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE ISOLATION; PATIENT ASSESSMENT; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PREDICTION; PREVALENCE; PROTEIN DETERMINATION; PROTEIN FUNCTION; SEQUENCE ANALYSIS;

ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; BRAZIL; CROSS PROTECTION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALARIA, FALCIPARUM; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS;

EID: 84891010620     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-608     Document Type: Article

References (73)

1. Vitoria M, Granich R, Gilks CF, Gunneberg C, Hosseini M, Were W, Raviglione M, De Cock KM. The global fight against HIV/AIDS, tuberculosis, and malaria: current status and future perspectives. Am J Clin Pathol 2009, 131:844-848. 10.1309/AJCP5XHDB1PNAEYT, 19461091.
2. Okumu FO, Moore SJ. Combining indoor residual spraying and insecticide-treated nets for malaria control in Africa: a review of possible outcomes and an outline of suggestions for the future. Malar J 2011, 10:208. 10.1186/1475-2875-10-208, 3155911, 21798053.
3. WHO World Malaria Report:2010 2010, 94. Geneva: World Health Organization, WHO.
4. Agnandji ST, Lell B, Soulanoudjingar SS, Fernandes JF, Abossolo BP, Conzelmann C, Methogo BGNO, Doucka Y, Flamen A, Mordmüller B, Issifou S, Kremsner PG, Sacarlal J, Aide P, Lanaspa M, Aponte JJ, Nhamuave A, Quelhas D, Bassat Q, Mandjate S, Macete E, Alonso P, Abdulla S, Salim N, Juma O, Shomari M, Shubis K, Machera F, Hamad AS, Minja R, et al. First results of phase 3 trial of RTS, S/AS01 malaria vaccine in African children. N Engl J Med 2011, 365:1863-1875.
5. Matuschewski K, Hafalla JC, Borrmann S, Friesen J. Arrested Plasmodium liver stages as experimental anti-malaria vaccines. Hum Vaccin 2011, 7(Suppl):16-21.
6. Cohen S, Mc GI, Carrington S. Gamma-globulin and acquired immunity to human malaria. Nature 1961, 192:733-737. 10.1038/192733a0, 13880318.
7. Riglar DT, Richard D, Wilson DW, Boyle MJ, Dekiwadia C, Turnbull L, Angrisano F, Marapana DS, Rogers KL, Whitchurch CB, Beeson JG, Cowman AF, Ralph SA, Baum J. Super-resolution dissection of coordinated events during malaria parasite invasion of the human erythrocyte. Cell Host Microbe 2011, 9:9-20. 10.1016/j.chom.2010.12.003, 21238943.
8. Cowman AF, Berry D, Baum J. The cell biology of disease: The cellular and molecular basis for malaria parasite invasion of the human red blood cell. J Cell Biol 2012, 198:961-971. 10.1083/jcb.201206112, 3444787, 22986493.
9. Polley SD, Tetteh KK, Lloyd JM, Akpogheneta OJ, Greenwood BM, Bojang KA, Conway DJ. Plasmodium falciparum merozoite surface protein 3 is a target of allele-specific immunity and alleles are maintained by natural selection. J Infect Dis 2007, 195:279-287. 10.1086/509806, 17191173.
10. Woehlbier U, Epp C, Hackett F, Blackman MJ, Bujard H. Antibodies against multiple merozoite surface antigens of the human malaria parasite Plasmodium falciparum inhibit parasite maturation and red blood cell invasion. Malar J 2010, 9:77. 10.1186/1475-2875-9-77, 2847572, 20298576.
11. Roussilhon C, Oeuvray C, Muller-Graf C, Tall A, Rogier C, Trape JF, Theisen M, Balde A, Perignon JL, Druilhe P. Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3. PLoS Med 2007, 4:e320. 10.1371/journal.pmed.0040320, 2071934, 18001147.
12. Osier FH, Fegan G, Polley SD, Murungi L, Verra F, Tetteh KK, Lowe B, Mwangi T, Bull PC, Thomas AW, Cavanagh DR, McBride JS, Lanar DE, Mackinnon MJ, Conway DJ, Marsh K. Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria. Infect Immun 2008, 76:2240-2248. 10.1128/IAI.01585-07, 2346713, 18316390.
13. Fowkes FJ, Richards JS, Simpson JA, Beeson JG. The relationship between anti-merozoite antibodies and incidence of Plasmodium falciparum malaria: A systematic review and meta-analysis. PLoS Med 2010, 7:e1000218. 10.1371/journal.pmed.1000218, 2808214, 20098724.
14. Osier FH, Murungi LM, Fegan G, Tuju J, Tetteh KK, Bull PC, Conway DJ, Marsh K. Allele-specific antibodies to Plasmodium falciparum merozoite surface protein-2 and protection against clinical malaria. Parasite Immunol 2010, 32:193-201. 10.1111/j.1365-3024.2009.01178.x, 2847195, 20398182.
15. Dodoo D, Atuguba F, Bosomprah S, Ansah NA, Ansah P, Lamptey H, Egyir B, Oduro AR, Gyan B, Hodgson A, Koram KA. Antibody levels to multiple malaria vaccine candidate antigens in relation to clinical malaria episodes in children in the Kasena-Nankana district of Northern Ghana. Malar J 2011, 10:108. 10.1186/1475-2875-10-108, 3101166, 21529376.
16. Dodoo D, Hollingdale MR, Anum D, Koram KA, Gyan B, Akanmori BD, Ocran J, Adu-Amankwah S, Geneshan H, Abot E, Legano J, Banania G, Sayo R, Brambilla D, Kumar S, Doolan DL, Rogers WO, Epstein J, Richie TL, Sedegah M. Measuring naturally acquired immune responses to candidate malaria vaccine antigens in Ghanaian adults. Malar J 2011, 10:168. 10.1186/1475-2875-10-168, 3132199, 21689436.
17. McCarra MB, Ayodo G, Sumba PO, Kazura JW, Moormann AM, Narum DL, John CC. Antibodies to Plasmodium falciparum Erythrocyte-binding Antigen-175 are Associated With Protection From Clinical Malaria. Pediatr Infect Dis J 2011, 30:1037-1042. 10.1097/INF.0b013e31822d1451, 3222715, 21817955.
18. Esen M, Kremsner PG, Schleucher R, Gassler M, Imoukhuede EB, Imbault N, Leroy O, Jepsen S, Knudsen BW, Schumm M, Knobloch J, Theisen M, Mordmuller B. Safety and immunogenicity of GMZ2 - a MSP3-GLURP fusion protein malaria vaccine candidate. Vaccine 2009, 27:6862-6868. 10.1016/j.vaccine.2009.09.011, 19755144.
19. Nebie I, Diarra A, Ouedraogo A, Tiono AB, Konate AT, Gansane A, Soulama I, Cousens S, Leroy O, Sirima SB. Humoral and cell-mediated immunity to MSP3 peptides in adults immunized with MSP3 in malaria endemic area, Burkina Faso. Parasite Immunol 2009, 31:474-480. 10.1111/j.1365-3024.2009.01130.x, 2759983, 19646212.
20. Crompton PD, Pierce SK, Miller LH. Advances and challenges in malaria vaccine development. J Clin Invest 2010, 120:4168-4178. 10.1172/JCI44423, 2994342, 21123952.
21. Sirima SB, Cousens S, Druilhe P. Protection against malaria by MSP3 candidate vaccine. N Engl J Med 2011, 365:1062-1064. 10.1056/NEJMc1100670, 21916656.
22. Oliveira-Ferreira J, Lacerda MV, Brasil P, Ladislau JL, Tauil PL, Daniel-Ribeiro CT. Malaria in Brazil: an overview. Malar J 2010, 9:115. 10.1186/1475-2875-9-115, 2891813, 20433744.
23. Camargo EP. A malária encenada no grande teatro social. Estudos Avançados 1995, 9:211-228.
24. Katsuragawa TH, Gil LH, Tada MS, de Almeida e Silva A, Costa JD, Araujo Mda S, Escobar AL, da Silva LH. The dynamics of transmission and spatial distribution of malaria in riverside areas of Porto Velho, Rondonia, in the Amazon region of Brazil. PLoS One 2010, 5:e9245. 10.1371/journal.pone.0009245, 2821918, 20169070.
25. Griffing SM, Mixson-Hayden T, Sridaran S, Alam MT, McCollum AM, Cabezas C, Marquino Quezada W, Barnwell JW, De Oliveira AM, Lucas C, Arrospide N, Escalante AA, Bacon DJ, Udhayakumar V. South American Plasmodium falciparum after the malaria eradication era: clonal population expansion and survival of the fittest hybrids. PLoS One 2011, 6:e23486. 10.1371/journal.pone.0023486, 3174945, 21949680.
26. Branch OH, Sutton PL, Barnes C, Castro JC, Hussin J, Awadalla P, Hijar G. Plasmodium falciparum genetic diversity maintained and amplified over 5 years of a low transmission endemic in the Peruvian Amazon. Mol Biol Evol 2011, 28:1973-1986. 10.1093/molbev/msq311, 3112368, 21109587.
27. Albrecht L, Castineiras C, Carvalho BO, Ladeia-Andrade S, Santos da Silva N, Hoffmann EH, dalla Martha RC, Costa FT, Wunderlich G. The South American Plasmodium falciparum var gene repertoire is limited, highly shared and possibly lacks several antigenic types. Gene 2010, 453:37-44. 10.1016/j.gene.2010.01.001, 20079817.
28. Alves FP, Durlacher RR, Menezes MJ, Krieger H, Silva LH, Camargo EP. High prevalence of asymptomatic Plasmodium vivax and Plasmodium falciparum infections in native Amazonian populations. Am J Trop Med Hyg 2002, 66:641-648.
29. Alves FP, Gil LH, Marrelli MT, Ribolla PE, Camargo EP, Da Silva LH. Asymptomatic carriers of Plasmodium spp. as infection source for malaria vector mosquitoes in the Brazilian Amazon. J Med Entomol 2005, 42:777-779. 10.1603/0022-2585(2005)042[0777:ACOPSA]2.0.CO;2, 16363160.
30. Snounou G. Detection and identification of the four malaria parasite species infecting humans by PCR amplification. Methods in Molecular Biology-Species Diagnostics Protocols: PCR and Other Nucleic Acid Methods. Volume 50 1996, 263-291. Totowa, NJ: Humana Press, Inc, Clapp JP.
31. Ferreira MU, Liu Q, Kaneko O, Kimura M, Tanabe K, Kimura EA, Katzin AM, Isomura S, Kawamoto F. Allelic diversity at the merozoite surface protein-1 locus of Plasmodium falciparum in clinical isolates from the southwestern Brazilian Amazon. Am J Trop Med Hyg 1998, 59:474-480.
32. Tonhosolo R, Wunderlich G, Ferreira MU. Differential antibody recognition of four allelic variants of the merozoite surface protein-2 (MSP-2) of Plasmodium falciparum. J Eukaryot Microbiol 2001, 48:556-564. 10.1111/j.1550-7408.2001.tb00191.x, 11596920.
33. Ghai M, Dutta S, Hall T, Freilich D, Ockenhouse CF. Identification, expression, and functional characterization of MAEBL, a sporozoite and asexual blood stage chimeric erythrocyte-binding protein of Plasmodium falciparum. Mol Biochem Parasitol 2002, 123:35-45. 10.1016/S0166-6851(02)00123-8, 12165387.
34. Noranate N, Prugnolle F, Jouin H, Tall A, Marrama L, Sokhna C, Ekala MT, Guillotte M, Bischoff E, Bouchier C, Patarapotikul J, Ohashi J, Trape JF, Rogier C, Mercereau-Puijalon O. Population diversity and antibody selective pressure to Plasmodium falciparum MSP1 block2 locus in an African malaria-endemic setting. BMC Microbiol 2009, 9:219. 10.1186/1471-2180-9-219, 2770483, 19832989.
35. Hoffmann EH, da Silveira LA, Tonhosolo R, Pereira FJ, Ribeiro WL, Tonon AP, Kawamoto F, Ferreira MU. Geographical patterns of allelic diversity in the Plasmodium falciparum malaria-vaccine candidate, merozoite surface protein-2. Ann Trop Med Parasitol 2001, 95:117-132. 10.1080/00034980120045833, 11299119.
36. Butler NS, Moebius J, Pewe LL, Traore B, Doumbo OK, Tygrett LT, Waldschmidt TJ, Crompton PD, Harty JT. Therapeutic blockade of PD-L1 and LAG-3 rapidly clears established blood-stage Plasmodium infection. Nat Immunol 2012, 13:188-195.
37. Sun T, Holowka T, Song Y, Zierow S, Leng L, Chen Y, Xiong H, Griffith J, Nouraie M, Thuma PE, Lolis E, Janse CJ, Gordeuk VR, Augustijn K, Bucala R. A Plasmodium-encoded cytokine suppresses T-cell immunity during malaria. Proc Natl Acad Sci U S A 2012, 109:E2117-E2126. 10.1073/pnas.1206573109, 3411961, 22778413.
38. Marsh K, Kinyanjui S. Immune effector mechanisms in malaria. Parasite Immunol 2006, 28:51-60. 10.1111/j.1365-3024.2006.00808.x, 16438676.
39. Douglas AD, Williams AR, Illingworth JJ, Kamuyu G, Biswas S, Goodman AL, Wyllie DH, Crosnier C, Miura K, Wright GJ, Long CA, Osier FH, Marsh K, Turner AV, Hill AVS, Draper SJ. The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody. Nat Commun 2011, 2:601. 3504505, 22186897.
40. Crompton PD, Kayala MA, Traore B, Kayentao K, Ongoiba A, Weiss GE, Molina DM, Burk CR, Waisberg M, Jasinskas A, Tan X, Doumbo S, Doumtabe D, Kone Y, Narum DL, Liang X, Doumbo OK, Miller LH, Doolan DL, Baldi P, Felgner PL, Pierce SK. A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray. Proc Natl Acad Sci U S A 2010, 107:6958-6963. 10.1073/pnas.1001323107, 2872454, 20351286.
41. Gil LH, Alves FP, Zieler H, Salcedo JM, Durlacher RR, Cunha RP, Tada MS, Camargo LM, Camargo EP, Pereira-da-Silva LH. Seasonal malaria transmission and variation of anopheline density in two distinct endemic areas in Brazilian Amazonia. J Med Entomol 2003, 40:636-641. 10.1603/0022-2585-40.5.636, 14596276.
42. Da Silveira LA, Ribeiro WL, Kirchgatter K, Wunderlich G, Matsuoka H, Tanabe K, Ferreira MU. Sequence diversity and linkage disequilibrium within the merozoite surface protein-1 (Msp-1) locus of Plasmodium falciparum: a longitudinal study in Brazil. J Eukaryot Microbiol 2001, 48:433-439. 10.1111/j.1550-7408.2001.tb00176.x, 11456319.
43. dalla Martha RC, Tada MS, de Mattos Ferreira RG, da Silva LHP, Wunderlich G. Microsatellite characterization of Plasmodium falciparum from symptomatic and non-symptomatic infections from the Western Amazon reveals the existence of non-symptomatic infection-associated genotypes. Mem Inst Oswaldo Cruz 2007, 102:293-298. 10.1590/S0074-02762007005000044, 17568933.
44. O'Donnell RA, de Koning-Ward TF, Burt RA, Bockarie M, Reeder JC, Cowman AF, Crabb BS. Antibodies against merozoite surface protein (MSP)-1(19) are a major component of the invasion-inhibitory response in individuals immune to malaria. J Exp Med 2001, 193:1403-1412. 10.1084/jem.193.12.1403, 2193299, 11413195.
45. Jordan SJ, Oliveira AL, Hernandez JN, Oster RA, Chattopadhyay D, Branch OH, Rayner JC. Malaria immunoepidemiology in low transmission: correlation of infecting genotype and immune response to domains of Plasmodium falciparum merozoite surface protein 3. Infect Immun 2011, 79:2070-2078. 10.1128/IAI.01332-10, 3088150, 21383051.
46. Neal AT, Jordan SJ, Oliveira AL, Hernandez JN, Branch OH, Rayner JC. Limited variation in vaccine candidate Plasmodium falciparum Merozoite Surface Protein-6 over multiple transmission seasons. Malar J 2010, 9:138. 10.1186/1475-2875-9-138, 2881939, 20497564.
47. Gray JC, Corran PH, Mangia E, Gaunt MW, Li Q, Tetteh KKA, Polley SD, Conway DJ, Holder AA, Bacarese-Hamilton T, Riley EM, Crisanti A. Profiling the antibody immune response against blood stage malaria vaccine candidates. Clin Chem 2007, 53:1244-1253. 10.1373/clinchem.2006.081695, 17510307.
48. Polley SD, Conway DJ, Cavanagh DR, McBride JS, Lowe BS, Williams TN, Mwangi TW, Marsh K. High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal Kenya. Vaccine 2006, 24:4233-4246. 10.1016/j.vaccine.2005.06.030, 16111789.
49. Joos C, Marrama L, Polson HE, Corre S, Diatta AM, Diouf B, Trape JF, Tall A, Longacre S, Perraut R. Clinical protection from falciparum malaria correlates with neutrophil respiratory bursts induced by merozoites opsonized with human serum antibodies. PLoS One 2010, 5:e9871. 10.1371/journal.pone.0009871, 2845614, 20360847.
50. Duah NO, Miles DJC, Whittle HC, Conway DJ. Acquisition of antibody isotypes against Plasmodium falciparum blood stage antigens in a birth cohort. Parasite Immunol 2010, 32:125-134. 10.1111/j.1365-3024.2009.01165.x, 2814092, 20070826.
51. Baumann A, Magris MM, Urbaez M-L, Vivas-Martinez S, Durán R, Nieves T, Esen M, Mordmüller BG, Theisen M, Avilan L, Metzger WG. Naturally acquired immune responses to malaria vaccine candidate antigens MSP3 and GLURP in Guahibo and Piaroa indigenous communities of the Venezuelan Amazon. Malar J 2012, 11:46. 10.1186/1475-2875-11-46, 3296639, 22335967.
52. Jordan SJ, Branch OH, Castro JC, Castro JC, Oster RA, Rayner JC. Genetic diversity of the malaria vaccine candidate Plasmodium falciparum merozoite surface protein-3 in a hypoendemic transmission environment. Am J Trop Med Hyg 2009, 80:479-486. 2723947, 19270302.
53. Oeuvray C, Bouharoun-Tayoun H, Gras-Masse H, Bottius E, Kaidoh T, Aikawa M, Filgueira MC, Tartar A, Druilhe P. Merozoite surface protein-3: a malaria protein inducing antibodies that promote Plasmodium falciparum killing by cooperation with blood monocytes. Blood 1994, 84:1594-1602.
54. Bai T, Becker M, Gupta A, Strike P, Murphy VJ, Anders RF, Batchelor AH. Structure of AMA1 from Plasmodium falciparum reveals a clustering of polymorphisms that surround a conserved hydrophobic pocket. Proc Natl Acad Sci U S A 2005, 102:12736-12741. 10.1073/pnas.0501808102, 1200259, 16129835.
55. Healer J, Murphy V, Hodder AN, Masciantonio R, Gemmill AW, Anders RF, Cowman AF, Batchelor A. Allelic polymorphisms in apical membrane antigen-1 are responsible for evasion of antibody-mediated inhibition in Plasmodium falciparum. Mol Microbiol 2004, 52:159-168. 10.1111/j.1365-2958.2003.03974.x, 15049818.
56. Escalante AA, Grebert HM, Chaiyaroj SC, Magris M, Biswas S, Nahlen BL, Lal AA. Polymorphism in the gene encoding the apical membrane antigen-1 (AMA-1) of Plasmodium falciparum. X. Asembo Bay Cohort Project. Mol Biochem Parasitol 2001, 113:279-287. 10.1016/S0166-6851(01)00229-8, 11295182.
57. Siddiqui WA, Tam LQ, Kramer KJ, Hui GS, Case SE, Yamaga KM, Chang SP, Chan EB, Kan SC. Merozoite surface coat precursor protein completely protects Aotus monkeys against Plasmodium falciparum malaria. Proc Natl Acad Sci U S A 1987, 84:3014-3018. 10.1073/pnas.84.9.3014, 304791, 3554251.
58. Polley SD, Tetteh KK, Cavanagh DR, Pearce RJ, Lloyd JM, Bojang KA, Okenu DM, Greenwood BM, McBride JS, Conway DJ. Repeat sequences in block 2 of Plasmodium falciparum merozoite surface protein 1 are targets of antibodies associated with protection from malaria. Infect Immun 2003, 71:1833-1842. 10.1128/IAI.71.4.1833-1842.2003, 152097, 12654798.
59. Cavanagh DR, Elhassan IM, Roper C, Robinson VJ, Giha H, Holder AA, Hviid L, Theander TG, Arnot DE, McBride JS. A longitudinal study of type-specific antibody responses to Plasmodium falciparum merozoite surface protein-1 in an area of unstable malaria in Sudan. J Immunol 1998, 161:347-359.
60. Scopel KK, Fontes CJ, Ferreira MU, Braga EM. Plasmodium falciparum: IgG subclass antibody response to merozoite surface protein-1 among Amazonian gold miners, in relation to infection status and disease expression. Exp Parasitol 2005, 109:124-134. 10.1016/j.exppara.2004.12.002, 15687019.
61. Etlinger HM, Caspers P, Matile H, Schoenfeld HJ, Stueber D, Takacs B. Ability of recombinant or native proteins to protect monkeys against heterologous challenge with Plasmodium falciparum. Infect Immun 1991, 59:3498-3503. 258912, 1894356.
62. Lazarou M, Patino JA, Jennings RM, McIntosh RS, Shi J, Howell S, Cullen E, Jones T, Adame-Gallegos JR, Chappel JA, McBride JS, Blackman MJ, Holder AA, Pleass RJ. Inhibition of erythrocyte invasion and Plasmodium falciparum merozoite surface protein 1 processing by human immunoglobulin G1 (IgG1) and IgG3 antibodies. Infect Immun 2009, 77:5659-5667. 10.1128/IAI.00167-09, 2786472, 19805526.
63. Lucchi NW, Tongren JE, Jain V, Nagpal AC, Kauth CW, Woehlbier U, Bujard H, Dash AP, Singh N, Stiles JK, Udhayakumar V. Antibody responses to the merozoite surface protein-1 complex in cerebral malaria patients in India. Malar J 2008, 7:121. 10.1186/1475-2875-7-121, 2491629, 18601721.
64. Jordan SJ, Oliveira AL, Neal AT, Hernandez JN, Branch OH, Rayner JC. Antibodies directed against merozoite surface protein-6 are induced by natural exposure to Plasmodium falciparum in a low transmission environment. Parasite Immunol 2011, 33:401-410. 10.1111/j.1365-3024.2011.01299.x, 21585398.
65. Wu T, Black CG, Wang L, Hibbs AR, Coppel RL. Lack of sequence diversity in the gene encoding merozoite surface protein 5 of Plasmodium falciparum. Mol Biochem Parasitol 1999, 103:243-250. 10.1016/S0166-6851(99)00134-6, 10551366.
66. Nwagwu M, Haynes JD, Orlandi PA, Chulay JD. Plasmodium falciparum: chymotryptic-like proteolysis associated with a 101-kDa acidic-basic repeat antigen. Exp Parasitol 1992, 75:399-414. 10.1016/0014-4894(92)90253-7, 1493872.
67. Kariuki MM, Li X, Yamodo I, Chishti AH, Oh SS. Two Plasmodium falciparum merozoite proteins binding to erythrocyte band 3 form a direct complex. Biochem Biophys Res Commun 2005, 338:1690-1695. 10.1016/j.bbrc.2005.10.154, 16289042.
68. Duraisingh MT, Maier AG, Triglia T, Cowman AF. Erythrocyte-binding antigen 175 mediates invasion in Plasmodium falciparum utilizing sialic acid-dependent and -independent pathways. Proc Natl Acad Sci U S A 2003, 100:4796-4801. 10.1073/pnas.0730883100, 153635, 12672957.
69. Sanders PR, Kats LM, Drew DR, O'Donnell RA, O'Neill M, Maier AG, Coppel RL, Crabb BS. A set of glycosylphosphatidyl inositol-anchored membrane proteins of Plasmodium falciparum is refractory to genetic deletion. Infect Immun 2006, 74:4330-4338. 10.1128/IAI.00054-06, 1489731, 16790807.
70. Woodberry T, Minigo G, Piera KA, Hanley JC, de Silva HD, Salwati E, Kenangalem E, Tjitra E, Coppel RL, Price RN, Anstey NM, Plebanski M. Antibodies to Plasmodium falciparum and Plasmodium vivax merozoite surface protein 5 in Indonesia: species-specific and cross-reactive responses. J Infect Dis 2008, 198:134-142. 10.1086/588711, 18471084.
71. Richards JS, Stanisic DI, Fowkes FJI, Tavul L, Dabod E, Thompson JK, Kumar S, Chitnis CE, Narum DL, Michon P, Siba PM, Cowman AF, Mueller I, Beeson JG. Association between naturally acquired antibodies to erythrocyte-binding antigens of Plasmodium falciparum and protection from malaria and high-density parasitemia. Clin Infect Dis : an official publication of the Infectious Diseases Society of America 2010, 51:e50-e60.
72. Williams AR, Douglas AD, Miura K, Illingworth JJ, Choudhary P, Murungi LM, Furze JM, Diouf A, Miotto O, Crosnier C, Wright GJ, Kwiatkowski DP, Fairhurst RM, Long CA, Draper SJ. Enhancing blockade of Plasmodium falciparum erythrocyte invasion: assessing combinations of antibodies against PfRH5 and other merozoite antigens. PLoS Pathog 2012, 8:e1002991. 10.1371/journal.ppat.1002991, 3493472, 23144611.
73. Weiss GE, Traore B, Kayentao K, Ongoiba A, Doumbo S, Doumtabe D, Kone Y, Dia S, Guindo A, Traore A, Huang CY, Miura K, Mircetic M, Li S, Baughman A, Narum DL, Miller LH, Doumbo OK, Pierce SK, Crompton PD. The Plasmodium falciparum-specific human memory B cell compartment expands gradually with repeated malaria infections. PLoS Pathog 2010, 6:e1000912. 10.1371/journal.ppat.1000912, 2873912, 20502681.